 CARLSBAD, Calif., June 10, 2021 PRNewswire -- Ionis Pharmaceuticals, Inc. NASDAQ: IONS, the leader in RNA-targeted therapies, today announced that multiple presentations highlighting advances in its ATTR amyloidosis programs will be featured during the 2021 Peripheral Nerve Society PNS Annual Meeting to be held virtually on June 12-13, and 25-27, 2021. 